Bikoff Maxwell 4

What Happened

• Bikoff Maxwell, a director of Mobia Medical, received a derivative award on 2026-05-07 consisting of options covering 31,520 shares. The grant is reported at an acquisition price of $0.00 (total reported value $0), indicating an option/award rather than a cash purchase.

Key Details

• Transaction date: 2026-05-07; Form 4 filed: 2026-05-11 (filed 4 days after the transaction).
• Transaction type/code: Award/Grant of derivative securities (A).
• Shares/options granted: 31,520; reported acquisition price: $0.00; reported total value: $0.
• Shares owned after transaction: not disclosed in the filing.
• Footnote: The stock option will vest in three substantially equal installments on the first three anniversaries of the grant date.

Context

• This was a grant of stock options (a derivative award) that vests over time — not an immediate open-market purchase or sale. Such grants are common for compensation and do not, by themselves, indicate a purchase or sale sentiment. Note the Form 4 was filed several days after the grant date, which appears later than the typical two-business-day reporting requirement under Section 16.